☰

Scott L. Pomeroy

Affiliations: 
Neurology Harvard Medical School - Boston Children's Hospital 
Area:
embryonal brain tumors, cell proliferation and differentiation
Google:
"Scott Pomeroy"
Mean distance: 13.48 (cluster 11)
 		SNBCP
Cross-listing:

Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
David G. Nathan post-doc 1982-1984 Harvard - Boston Children's Hospital
Philip Rodgers Dodge post-doc 1987-1990 Washington University
Dale Purves post-doc 1987-1990 Washington University

Children

Sign in to add trainee
Rejean M. Guerriero post-doc Harvard Medical School/Children's Hospital
Tenley Archer post-doc 2011- Harvard Medical School/Children's Hospital
Joao O. Siffert post-doc 1993-1994 Harvard Medical School/Children's Hospital
Mary  E. Sutton post-doc 1994-1997 Harvard Medical School/Children's Hospital
John Y. Kim post-doc 1997-2002 Harvard Medical School/Children's Hospital
Lisa Sturla post-doc 2000-2003 Harvard Medical School/Children's Hospital
Stephanie Greene post-doc 2001-2003 Harvard Medical School/Children's Hospital
Nicole J. Ullrich post-doc 2001-2004 Harvard Medical School/Children's Hospital
Roger  P. Leng post-doc 2004-2006 Harvard Medical School/Children's Hospital
Manuel Ferreira post-doc 2006-2009 Harvard Medical School/Children's Hospital
Yoon-Jae Cho post-doc 2007-2010 Harvard Medical School/Children's Hospital
S. Dilhan Weeraratne post-doc 2008-2012 Harvard Medical School/Children's Hospital
Soma Sengupta post-doc 2010-2015 University of Cincinnati

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McArthur JC, Augustine EF, Carmichael ST, et al. (2023) Recognizing and responding to the needs of future child and adult neurology care through the evolution of residency training. Annals of Neurology
Maynard R, Poore B, Hanaford AR, et al. (2021) TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters
Bhattacharya D, Pomeroy SL, Pomeranz Krummel DA, et al. (2020) Epigenetics and survivorship in pediatric brain tumor patients. Journal of Neuro-Oncology
Li BK, Vasiljevic A, Dufour C, et al. (2019) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathologica
Zhang L, He X, Liu X, et al. (2019) Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse. Cancer Cell
Hovestadt V, Smith KS, Bihannic L, et al. (2019) Resolving medulloblastoma cellular architecture by single-cell genomics. Nature
Bihannic L, Hovestadt V, Smith K, et al. (2019) PDTM-32. RESOLVING MEDULLOBLASTOMA CELLULAR ARCHITECTURE BY SINGLE-CELL GENOMICS Neuro-Oncology. 21: vi194-vi194
Archer TC, Ehrenberger T, Mundt F, et al. (2018) Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 34: 396-410.e8
Clark AR, Calligaris D, Regan MS, et al. (2018) Rapid discrimination of pediatric brain tumors by mass spectrometry imaging. Journal of Neuro-Oncology
Waszak SM, Northcott PA, Buchhalter I, et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. The Lancet. Oncology
See more...